Infiltrative capacity of T leukemia cell lines: A distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1)

被引:34
|
作者
Ivanoff, A
Ivanoff, J
Hultenby, K
Sundqvist, KG [1 ]
机构
[1] Umea Univ, Dept Clin Immunol, S-90185 Umea, Sweden
[2] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Immunol, S-14186 Huddinge, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, S-14186 Huddinge, Sweden
关键词
extracellular matrix; lymphocyte infiltration; lymphocyte migration; metalloproteinase; tissue inhibitor of metalloproteinase;
D O I
10.1023/A:1006749304315
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infiltrative capacity was found to distinguish separate T leukemia cell lines. Of seven T-cell lines four exhibited capacity to infiltrate Matrigel. Analysis of infiltration was performed at the single-cell level throughout the Matrigel using a depth meter. Further, we examined differences in migration capacity and metalloproteinase production between infiltrating and non-infiltrating T-cell lines. The capacity to infiltrate was not directly correlated to the capacity to adhere to the Matrigel or to migrate on/to extracellular matrix components. It is concluded that infiltration capacity does not simply reflect capacity to migrate but represents a distinct functional property. The production of metalloproteinases and their inhibitors by the separate T-cell lines was analyzed using rt PCR, biosynthetic labelling, zymography, immunoprecipitation and ELISA. All T-cell lines with capacity to infiltrate produced matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) while non-infiltrating cell lines did not express MMP-9. Expression of MMP-1, 2, 3, 10, 14 and 17 showed no correlation to capacity to infiltrate. Analysis of infiltration in the presence of a metalloprotease inhibitor showed an increased number of cells within the gel. This enhancement of infiltration suggests that the function of MMPs and/or their inhibitors in lymphocyte infiltration is more complex than previously thought.
引用
收藏
页码:695 / 711
页数:17
相关论文
共 50 条
  • [21] Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients
    Mroczko, Barbara
    Groblewska, Magdalena
    Lukaszewicz-Zajac, Marta
    Bandurski, Roman
    Kedra, Boguslaw
    Szmitkowski, Maciej
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (09) : 1133 - 1139
  • [22] Expression of metalloproteinases MMP-1 and MMP-9 and tissue inhibitor of metalloproteinases TIMP-1 in cases of endometrial carcinoma and endometrial hyperplasia
    Wlazlak, Edyta
    Surkont, Grzegorz
    Kobos, Jozef
    Tylinski, Wieslaw
    Stetkiewicz, Tomasz
    Suzin, Jacek
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2006, 5 (06): : 363 - 366
  • [23] Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention(PCI)
    Revnic, F.
    Revnic, C. R.
    Nica, A.
    Ginghina, C.
    Prada, G.
    Gradinaru, D.
    Prada, S.
    Sonea, C.
    Pena, C.
    CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION, 2011, : 49 - 52
  • [24] Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome
    Jensen, Soren Astrup
    Vainer, Ben
    Bartels, Annette
    Brunner, Nils
    Sorensen, Jens Benn
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) : 3233 - 3242
  • [25] The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey
    Caimi, Gregorio
    Hopps, Eugenia
    Montana, Maria
    Urso, Caterina
    Carollo, Caterina
    Canino, Baldassare
    Lo Presti, Rosalia
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2021, 78 (04) : 401 - 416
  • [26] Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Acute Pyelonephritis and Renal Scarring
    Milan Chromek
    Kjell Tullus
    Olof Hertting
    Georg Jaremko
    Adli Khalil
    Ying-Hua Li
    Annelie Brauner
    Pediatric Research, 2003, 53 : 698 - 705
  • [27] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring
    Chromek, M
    Tullus, K
    Hertting, O
    Jaremko, G
    Khalil, A
    Li, YH
    Brauner, A
    PEDIATRIC RESEARCH, 2003, 53 (04) : 698 - 705
  • [28] Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1:: expression in chronic sinusitis vs nasal polyposis
    Watelet, JB
    Bachert, C
    Claeys, C
    Van Cauwenberge, P
    ALLERGY, 2004, 59 (01) : 54 - 60
  • [29] Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia
    Saleh, Maha
    Khalil, Mohamed
    Abdellateif, Mona S.
    Ebeid, Emad
    Madney, Youssef
    Kandeel, Eman Z.
    HEMATOLOGY, 2021, 26 (01) : 758 - 768
  • [30] Use of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathomorphological diagnosis of carotid pathology: literature review and own observations
    Kuzyk, Yu. I.
    PATHOLOGIA, 2016, (01): : 37 - 44